Sezary syndrome in relapse after reduced intensity allogeneic transplant successfully treated with donor lymphocyte infusion

被引：9
|
作者：
Cudillo, L. [1 ]
Cerretti, R. [1 ]
Baliva, G. [2 ]
De Angelis, G. [1 ]
Postorino, M. [1 ]
Picardi, A. [1 ]
Mirabile, M. [1 ]
Lanti, A. [3 ]
Cantonetti, M. [1 ]
Arcese, W. [1 ]
机构：
[1] Univ Roma Tor Vergata, Stem Cell Transplant Unit, Rome, Italy
[2] IRCCS, Dermatopat Immacolata Inst, Rome, Italy
[3] Univ Roma Tor Vergata, Blood Bank, Rome, Italy
来源：
BONE MARROW TRANSPLANTATION | 2009年 / 43卷 / 04期
关键词：
STEM-CELL TRANSPLANTATION; ADVANCED MYCOSIS-FUNGOIDES;
D O I：
10.1038/bmt.2008.333
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：347 / 348
页数：2
相关论文
共 50 条
  • [41] Donor lymphocyte infusion for treatment of hematological leukemia relapse in children after allogeneic bone marrow transplantation.
    Pieczonka, A
    Wachowiak, J
    Boruczkowski, D
    Leda, M
    Jólkowska, J
    Ladoñ, D
    Witt, M
    BONE MARROW TRANSPLANTATION, 2002, 30 : S63 - S63
  • [42] Induction of remission after donor lymphocyte infusion following allogeneic transplant in a case of pediatric primary myelofibrosis
    Li, Amy
    Sze, Sei-Gyung K.
    Kapadia, Malika
    Lehmann, Leslie
    Bledsoe, Jacob R.
    Kennedy, Alyssa L.
    PEDIATRIC BLOOD & CANCER, 2024, 71 (10)
  • [43] αβ-T-cell depleted donor lymphocyte infusion for leukemia relapse after allogeneic stem cell transplantation
    Kordelas, L.
    Buttkereit, U.
    Lindemann, M.
    Koldehoff, M.
    Klisanin, V.
    Horn, P. A.
    Fleischhauer, K.
    Beelen, D. W.
    BONE MARROW TRANSPLANTATION, 2017, 52 (12) : 1668 - 1670
  • [44] Second allogeneic stem-cell transplantation or donor lymphocyte infusion in patients who relapse after transplantation?
    Robin, Marie
    LANCET HAEMATOLOGY, 2024, 11 (09): : e642 - e643
  • [45] αβ-T-cell depleted donor lymphocyte infusion for leukemia relapse after allogeneic stem cell transplantation
    L Kordelas
    U Buttkereit
    M Lindemann
    M Koldehoff
    V Klisanin
    P A Horn
    K Fleischhauer
    D W Beelen
    Bone Marrow Transplantation, 2017, 52 : 1668 - 1670
  • [46] Outcome of second allogeneic transplants using reduced intensity conditioning following relapse after an initial allogeneic transplant.
    Shaw, B. E.
    Mufti, G. J.
    Mackinnon, S.
    Cavenagh, J.
    Towlson, K.
    Pearce, R.
    Pagliuca, A.
    Apperley, J.
    Craddock, C.
    Kazmi, M.
    Littlewood, T.
    Milligan, D.
    Marks, D.
    Russell, Nigel H.
    BLOOD, 2006, 108 (11) : 1045A - 1046A
  • [47] Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse after an initial allogeneic transplant
    Shaw, B.
    Mufti, G. J.
    Mackinnon, S.
    Cavenagh, J.
    Towlson, K.
    Pearce, R.
    Pagliuca, A.
    Apperley, J.
    Craddock, C.
    Kazmi, M. A.
    Littlewood, T.
    Milligan, D.
    Thomson, K.
    Marks, D.
    Russell, N.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S16 - S16
  • [48] Donor lymphocyte infusion for a patient with relapsing myelodysplastic syndrome after allogeneic bone marrow transplantation
    Bressoud, A
    Chapuis, B
    Roux, E
    Cabrol, C
    Jeannet, M
    Roosnek, E
    Helg, C
    BLOOD, 1996, 88 (05) : 1902 - 1903
  • [49] Donor CD3+ lymphocyte infusion after reduced intensity conditioning allogeneic stem cell transplantation: Single-center experience
    El-Cheikh, Jean
    Crocchiolo, Roberto
    Furst, Sabine
    Ladaique, Patrick
    Castagna, Luca
    Faucher, Catherine
    Calmels, Boris
    Oudin, Claire
    Lemarie, Claude
    Granata, Angela
    Devillier, Raynier
    Vey, Norbert
    Bouabdallah, Reda
    Chabannon, Christian
    Blaise, Didier
    EXPERIMENTAL HEMATOLOGY, 2013, 41 (01) : 17 - 27
  • [50] Comparison of Outcomes After Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Lymphocyte Infusion in Allogeneic Hematopoietic Cell Transplant
    Al-Shaibani, Eshrak
    Bautista, Rhida
    Lipton, Jeffrey H.
    Kim, Dennis D.
    Viswabandya, Auro
    Kumar, Rajat
    Lam, Wilson
    Law, Arjun D.
    Al-Shaibani, Zeyad
    Gerbitz, Armin
    Pasic, Ivan
    Mattsson, Jonas
    Michelis, Fotios, V
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (05): : E327 - E334
12345